Germano Zampa

Civitavecchia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Cosmic-ray antinuclei as messengers of new physics: status and outlook for the new decade.

Cosmic-ray antinuclei as messengers of new physics: status and outlook for the new decade.

Journal: Journal of cosmology and astroparticle physics

Published: August 01, 2020

Highly Elevated Plasma γ-Glutamyltransferase Elevations: A Trait Caused by γ-Glutamyltransferase 1 Transmembrane Mutations.

Highly Elevated Plasma γ-Glutamyltransferase Elevations: A Trait Caused by γ-Glutamyltransferase 1 Transmembrane Mutations.

Journal: Hepatology (Baltimore, Md.)

Published: August 06, 2019

ESAS and FACT-B in eribulin-treated metastatic breast cancer patients: a multicenter, prospective and observational study.

ESAS and FACT-B in eribulin-treated metastatic breast cancer patients: a multicenter, prospective and observational study.

Journal: Future oncology (London, England)

Published: April 22, 2017

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience.

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience.

Journal: Oncotarget

Published: March 07, 2017

Bevacizumab as first-line treatment in HER2-negative advanced breast cancer: pros and cons.

Bevacizumab as first-line treatment in HER2-negative advanced breast cancer: pros and cons.

Journal: Tumori

Published: August 02, 2016

Time Dependence of the Electron and Positron Components of the Cosmic Radiation Measured by the PAMELA Experiment between July 2006 and December 2015.

Time Dependence of the Electron and Positron Components of the Cosmic Radiation Measured by the PAMELA Experiment between July 2006 and December 2015.

Journal: Physical review letters

Published: April 18, 2016

Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies.

Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies.

Journal: Expert review of vaccines

Published: April 12, 2016

Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis.

Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis.

Journal: PloS one

Published: February 17, 2016

New upper limit on strange quark matter abundance in cosmic rays with the PAMELA space experiment.

New upper limit on strange quark matter abundance in cosmic rays with the PAMELA space experiment.

Journal: Physical review letters

Published: July 10, 2015

Safety and efficacy of bevacizumab in combination with first-line chemotherapy in advanced breast cancer: data from the Italian cohort of the ATHENA trial.

Safety and efficacy of bevacizumab in combination with first-line chemotherapy in advanced breast cancer: data from the Italian cohort of the ATHENA trial.

Journal: Tumori

Published: October 10, 2014

Non-pegylated liposomal Doxorubicin-cyclophosphamide in sequential regimens with taxanes as neoadjuvant chemotherapy in breast cancer patients.

Non-pegylated liposomal Doxorubicin-cyclophosphamide in sequential regimens with taxanes as neoadjuvant chemotherapy in breast cancer patients.

Journal: Journal of Cancer

Published: March 17, 2014

Optimal tolerability and high efficacy of a modified schedule of lapatinib-capecitabine in advanced breast cancer patients.

Optimal tolerability and high efficacy of a modified schedule of lapatinib-capecitabine in advanced breast cancer patients.

Journal: Journal of cancer research and clinical oncology

Published: November 13, 2013

Showing 1-12 of 16

Last Updated: 09/26/2026